| LSHTM | London School of Hygiene and Tropical Medicine |
|---|---|
| MLCO | Member of the London College of Osteopathy |
| CAS | calcarine sulcus; calcific aortic stenosis; Cancer Attitude Survey; carbohydrate-active steroid; car... |
| CES-D | Center for Epidemiological Studies of Depression [scale] |
| CHAS | Center for Health Administration Studies |
| classical conditioning | <psychology> Learning that takes place when a conditioned stimulus is paired with an unconditioned stimulus. (12 Dec 1998) |
|---|---|
| classical confinement | <radiobiology> Plasma confinement in which particle and energy transport occurs via classical diffusion, best possible case for magnetically confined plasmas. See: classical diffusion. (09 Oct 1997) |
| classical diffusion | <radiobiology> In plasma physics, diffusion due solely to scattering (collisions) of charged particles (with unlike charges) via electrical (Coulomb) interactions. (See also diffusion.) (09 Oct 1997) |
| classical epidemiology | <epidemiology> Our term for the varieties of epidemiology primarily concerned with the statistical relationships between disease agents, both infectious and non-infectious; for example a study to establish the relative risk of lung cancer associated with smoking. We contrast this with ecological epidemiology. (05 Dec 1998) |
| classical genetics | That body of method and analysis that perceives genetics as the study of the transmission of genotype from parent to offspring; the study of multiple individuals is essential to it. (05 Mar 2000) |
| classical haemophilia | See: haemophilia A. (05 Mar 2000) |
| complement pathway, classical | The sequential activation of complement, initiated by antigen-antibody complex and the binding of complement factor c1q to the fc region of the antibody. (12 Dec 1998) |
| epidemiology, classical | The study of populations in order to determine the frequency and distribution of disease and measure risks. (12 Dec 1998) |
| retrospective studies | Studies used to test aetiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. (12 Dec 1998) |
| pharmalogical studies | <pharmacology> Studies to assess the potential harmful or other effects of drugs (16 Dec 1997) |
| clinical studies | <pharmacology> Human studies that are designed to measure the safety, efficacy, and appropriate dosage of a new drug or biological. Clinical studies routinely involve the use of a placebo group that is given an inactive substance that looks like the test product. (14 Nov 1997) |
| cohort studies | Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesised to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics. (12 Dec 1998) |
| combination studies | <pharmacology> Studies in which a new drug is evaluated in combination with existing drugs. (09 Jan 1998) |
| multicenter studies | Controlled studies which are planned and carried out by several cooperating institutions to assess certain variables and outcomes in specific patient populations, for example, a multicenter study of congenital anomalies in children. (12 Dec 1998) |
| multivariate studies | The use of statistical techniques for the simultaneous investigations of the influence of several variables. (05 Mar 2000) |